Wegovy Lowers the Risk of Cardiovascular Events by 20%

The maker of the weight-loss medication Wegovy, Novo Nordisk, claims that Wegovy lowers the risk of cardiovascular disease. According to a Novo Nordisk experiment, by 20% Wegovy lowers the risk of heart attack and stroke.

Wegovy Lowers the Risk of Cardiovascular Events by 20%
Wegovy Lowers the Risk of Cardiovascular Events by 20%

Wegovy Lowers the Risk of Cardiovascular Problems for What Reasons?

It’s a challenging topic to answer without having access to the complete study, according to specialists. They are aware that excess weight is a risk factor for heart disease, and it should be noted that weight loss is probably significant component in lowering risk.

Wegovy, a substance that helps people shed a lot of weight, continues to draw attention. According to Novo Nordisk, the drug’s maker, that isn’t all it can do. The weekly injectable medication, according to the manufacturer, Wegovy lowers the risk of significant cardiovascular consequences including heart attack and stroke. Wegovy lowers the risk of stroke, heart attack, and cardiovascular mortality by 20% when compared to patients who took a placebo, according to a press release from Novo Nordisk on Tuesday. That’s garnering a lot of interest and prompting some inquiries.

Reduce the Chance of Developing Cardiovascular Disease

The Life’s Essential elements to reduce your chance of acquiring cardiovascular disease are mentioned by Dr. Chen. These include giving up smoking, engaging in regular exercise, eating a nutritious diet, maintaining a healthy weight, controlling your blood sugar levels, maintaining good cholesterol and blood pressure levels, and obtaining seven to nine hours of sleep per night. Wegovy lowers the risk of cardiovascular disease preventative treatment is way too early to discuss.

Leave a Comment